NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Quarter ending 2026-12-30 | ||
| Revenue | — | 1.14M |
| EPS | — | -29.072 |
Management figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stabilize management team | A supporting condition in VERSUS SYSTEMS INC's published investment case. The stated target is No major executive departures in next 4 quarters. | Improving | Unexpected key executive departures occur | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce net losses to improve financial health | Versus Systems can improve its financial health by reversing its sharp revenue drop. | Intact | Net losses do not decrease or worsen over the next 4 quarters | Net income: $473,297 FY2026-Q2; GAAP. Published target: Net losses decrease by at least 20% year over year. Target and observation units differ. Source published Aug 14, 2026473,297 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 0fa6455f-2e7d-4020-af63-a170187784c1. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 quarters from 2025-Q3 through 2026-Q2. Operating income improved significantly from -$1.17M in 2025-Q4 to $594K in 2026-Q2, and net income turned positive from -$965K to $473K in the same period. This shows delivering progress on financial performance improvement. Delivery assessment Oct 24, 2026 |
Revenue improves from the 2026-Q1 trough | A primary condition in VERSUS SYSTEMS INC's published investment case. The stated target is Revenue > $1,000,000 next 4 quarters. | Intact | Revenue remains below $1,000,000 over the next 4 quarters | Revenue: $6,821 FY2026-Q2; GAAP. Published target: Revenue > $1,000,000 next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 14, 20266,821 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 0fa6455f-2e7d-4020-af63-a170187784c1. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 quarters from 2025-Q3 through 2026-Q2. Operating income improved significantly from -$1.17M in 2025-Q4 to $594K in 2026-Q2, and net income turned positive from -$965K to $473K in the same period. This shows delivering progress on financial performance improvement. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, loss-making business rather than an established compounder. The thesis is in a watch state: operating results improved through 2026-Q2, but recent signals turned cautious and confidence in the evidence is medium.
The valuation model indicates VS is expensive versus peers, with low confidence in that comparison and optionality as the stated reason for divergence. The evidence does not specify exactly what growth expectations are embedded in the valuation, so the expectations gap is unclear.
Near term, recent results show progress: operating income and net income improved from losses in 2025-Q4 to positive figures in 2026-Q2. But revenue fell between 2026-Q1 and Q2, and the recent performance remains below the industry cohort; the company also faces a high-risk profile, a recent CFO transition, and a history of a Nasdaq listing deficiency, despite equity later exceeding the stated minimum.
Over the next 1 to 3 years, the thesis hinges on whether improved profitability can persist and strategic partnerships begin to support meaningful revenue growth. A lower-rate backdrop and continued strength from sector bellwethers such as SAP, CRM, and NOW could help the sector setting, while weaker results or guidance from those peers could remove that support.
The multi-year view is cautious: financial progress is real, but revenue traction, execution, and the expensive peer comparison leave the thesis fragile. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.